These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

493 related articles for article (PubMed ID: 9562977)

  • 1. Basic fibroblast growth factor: a missing link between collagen VII, increased collagenase, and squamous cell carcinoma in recessive dystrophic epidermolysis bullosa.
    Arbiser JL; Fine JD; Murrell D; Paller A; Connors S; Keough K; Marsh E; Folkman J
    Mol Med; 1998 Mar; 4(3):191-5. PubMed ID: 9562977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on the pathogenesis of squamous cell carcinoma development in recessive dystrophic epidermolysis bullosa.
    Kim M; Murrell DF
    Eur J Dermatol; 2015 Apr; 25 Suppl 1():30-2. PubMed ID: 26083672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patients with recessive dystrophic epidermolysis bullosa develop squamous-cell carcinoma regardless of type VII collagen expression.
    Pourreyron C; Cox G; Mao X; Volz A; Baksh N; Wong T; Fassihi H; Arita K; O'Toole EA; Ocampo-Candiani J; Chen M; Hart IR; Bruckner-Tuderman L; Salas-Alanis JC; McGrath JA; Leigh IM; South AP
    J Invest Dermatol; 2007 Oct; 127(10):2438-44. PubMed ID: 17495952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inherited epidermolysis bullosa dystrophica and squamous cell carcinoma- A case report.
    Gayathri E; Anbukkarasi K; Lilly SM
    Indian J Pathol Microbiol; 2023; 66(2):360-362. PubMed ID: 37077084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unravelling drivers of cutaneous squamous cell carcinoma in recessive dystrophic epidermolysis bullosa.
    Santucci C; Alexandru M; Chen X; Mellerio JE; Karagiannis SN; Jacków-Malinowska J
    Hum Immunol; 2024 May; 85(3):110805. PubMed ID: 38703415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibroblast-derived dermal matrix drives development of aggressive cutaneous squamous cell carcinoma in patients with recessive dystrophic epidermolysis bullosa.
    Ng YZ; Pourreyron C; Salas-Alanis JC; Dayal JH; Cepeda-Valdes R; Yan W; Wright S; Chen M; Fine JD; Hogg FJ; McGrath JA; Murrell DF; Leigh IM; Lane EB; South AP
    Cancer Res; 2012 Jul; 72(14):3522-34. PubMed ID: 22564523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reprogramming and Differentiation of Cutaneous Squamous Cell Carcinoma Cells in Recessive Dystrophic Epidermolysis Bullosa.
    Rami A; Łaczmański Ł; Jacków-Nowicka J; Jacków J
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33383666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age and etiology of childhood epidermolysis bullosa mortality.
    Hon KL; Li JJ; Cheng BL; Luk DC; Murrell DF; Choi PC; Leung AK
    J Dermatolog Treat; 2015 Apr; 26(2):178-82. PubMed ID: 24724596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of the Timing of Milestone Clinical Events in Patients With Epidermolysis Bullosa From North America.
    Feinstein JA; Jambal P; Peoples K; Lucky AW; Khuu P; Tang JY; Lara-Corrales I; Pope E; Wiss K; Hook KP; Levin LE; Morel KD; Paller AS; McCuaig CC; Powell J; Eichenfield LF; Price H; Levy ML; Schachner LA; Browning JC; Bayliss S; Jahnke M; Shwayder T; Glick SA; Bruckner AL
    JAMA Dermatol; 2019 Feb; 155(2):196-203. PubMed ID: 30586139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Constitutive activation of the collagenase promoter in recessive dystrophic epidermolysis bullosa fibroblasts: role of endogenously activated AP-1.
    Unemori EN; Mauch C; Hoeffler W; Kim Y; Amento EP; Bauer EA
    Exp Cell Res; 1994 Apr; 211(2):212-8. PubMed ID: 8143767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TGFβ-signaling in squamous cell carcinoma occurring in recessive dystrophic epidermolysis bullosa.
    Knaup J; Gruber C; Krammer B; Ziegler V; Bauer J; Verwanger T
    Anal Cell Pathol (Amst); 2011; 34(6):339-53. PubMed ID: 22002724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recessive dystrophic epidermolysis bullosa-associated squamous-cell carcinoma: an enigmatic entity with complex pathogenesis.
    Rodeck U; Uitto J
    J Invest Dermatol; 2007 Oct; 127(10):2295-6. PubMed ID: 17853916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired Wound Healing, Fibrosis, and Cancer: The Paradigm of Recessive Dystrophic Epidermolysis Bullosa.
    Tartaglia G; Cao Q; Padron ZM; South AP
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High levels of type VII collagen expression in recessive dystrophic epidermolysis bullosa cutaneous squamous cell carcinoma keratinocytes increases PI3K and MAPK signalling, cell migration and invasion.
    Pourreyron C; Chen M; McGrath JA; Salas-Alanis JC; South AP; Leigh IM
    Br J Dermatol; 2014 Jun; 170(6):1256-65. PubMed ID: 24641191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of collagenase and stromelysin in skin fibroblasts from recessive dystrophic epidermolysis bullosa.
    Sato T; Nomura K; Hashimoto I
    Arch Dermatol Res; 1995; 287(5):428-33. PubMed ID: 7625851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase II randomized vehicle-controlled trial of intradermal allogeneic fibroblasts for recessive dystrophic epidermolysis bullosa.
    Venugopal SS; Yan W; Frew JW; Cohn HI; Rhodes LM; Tran K; Melbourne W; Nelson JA; Sturm M; Fogarty J; Marinkovich MP; Igawa S; Ishida-Yamamoto A; Murrell DF
    J Am Acad Dermatol; 2013 Dec; 69(6):898-908.e7. PubMed ID: 24075228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammation-mediated fibroblast activation and immune dysregulation in collagen VII-deficient skin.
    Anderson-Crannage M; Ascensión AM; Ibanez-Solé O; Zhu H; Schaefer E; Ottomanelli D; Hochberg B; Pan J; Luo W; Tian M; Chu Y; Cairo MS; Izeta A; Liao Y
    Front Immunol; 2023; 14():1211505. PubMed ID: 37809094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of p53 and p16 tumor suppressor genes in recessive dystrophic epidermolysis bullosa-associated squamous cell carcinoma.
    Arbiser JL; Fan CY; Su X; Van Emburgh BO; Cerimele F; Miller MS; Harvell J; Marinkovich MP
    J Invest Dermatol; 2004 Oct; 123(4):788-90. PubMed ID: 15373786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accelerated Aging and Microsatellite Instability in Recessive Dystrophic Epidermolysis Bullosa-Associated Cutaneous Squamous Cell Carcinoma.
    Lee CAA; Wu S; Chow YT; Kofman E; Williams V; Riddle M; Eide C; Ebens CL; Frank MH; Tolar J; Hook KP; AlDubayan SH; Frank NY
    J Invest Dermatol; 2024 Jul; 144(7):1534-1543.e2. PubMed ID: 38272206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term follow-up of patients with recessive dystrophic epidermolysis bullosa in the Netherlands: expansion of the mutation database and unusual phenotype-genotype correlations.
    van den Akker PC; van Essen AJ; Kraak MM; Meijer R; Nijenhuis M; Meijer G; Hofstra RM; Pas HH; Scheffer H; Jonkman MF
    J Dermatol Sci; 2009 Oct; 56(1):9-18. PubMed ID: 19665875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.